Clinical Trial

PD-1 mRNA LNP Vaccine for Advanced Primary Hepatocellular Carcinoma.

Recruiting Phase 1
View on ClinicalTrials.gov →
Summary
Evaluating the Safety and Efficacy of PD-1 mRNA LNP Vaccine Therapy in Patients with Primary Hepatocellular Carcinoma Who Have Failed Advanced Standard Therapy
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-06-30; most recent amendment 2026-04-19.
Status change: Not Yet Recruiting → Recruiting 2025-12-03
Trial Details
NCT Number NCT07053072
Lead Sponsor West China Hospital
Conditions Liver Cancer
Enrollment 9 participants
Start Date 2025-10-23
Primary Completion 2026-09-30 (estimated)
Study Completion 2026-12-30 (estimated)
Updated on ClinicalTrials.gov 2026-08-13